LCDActive
GlycoMark® Testing for Glycemic Control
L36864
Effective: October 16, 2025
Updated: December 31, 2025
Policy Summary
This policy declares the GlycoMark® assay (1,5-anhydroglucitol; Nippon Kayaku) non-covered for assessment of glycemic control. Claims for GlycoMark testing are not payable under this policy.
Coverage Criteria Preview
Key requirements from the full policy
"GlycoMark® assay (1,5-anhydroglucitol) testing is non-covered under this policy and is not a payable benefit."
Sign up to see full coverage criteria, indications, and limitations.
Covered Medical Codes